Viewing Study NCT03514069


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
Study NCT ID: NCT03514069
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-08
First Post: 2018-04-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
Sponsor: Case Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module